Brief: Active Biotech Announces Outcome Of Rights Issue
Dec 6 (Reuters) - Active Biotech AB publ ACTI.ST :
* ACTIVE BIOTECH ANNOUNCES OUTCOME OF THE COMPANY’S RIGHTS
ISSUE
* RECEIVES ISSUE PROCEEDS, IN CASH AND BY WAY OF SET-OFF,
AMOUNTING TO APPROXIMATELY SEK 43.5 MILLION, BEFORE ISSUE
EXPENSES
* 96,594,360 SHARES WERE SUBSCRIBED FOR, CORRESPONDING TO
ABOUT
85.0 PERCENT OF RIGHTS ISSUE
Source text for Eikon: ID:nMFN6d624T
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million